Complix's Series B Round

Complix raised a round of funding on June 26, 2013.

Complix is a biopharmaceutical company developing a pipeline of transformative protein therapeutics, called Alphabodies, that mainly focus on oncology and autoimmune diseases. Alphabodies are a class …

Articles about Complix's Series B Round: